162 related articles for article (PubMed ID: 37796708)
1. Potential Therapeutic Targets of Resveratrol in the Prevention and Treatment of Pulmonary Fibrosis.
Ramli I; Cheriet T; Posadino AM; Giordo R; Zayed H; Eid AH; Pintus G
Front Biosci (Landmark Ed); 2023 Sep; 28(9):198. PubMed ID: 37796708
[TBL] [Abstract][Full Text] [Related]
2. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
3. The evolving pharmacotherapy of pulmonary fibrosis.
Lota HK; Wells AU
Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy-Lysosome Pathway.
Bao L; Ye J; Liu N; Shao Y; Li W; Fan X; Zhao D; Wang H; Chen X
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500562
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib.
Wang D; Wei Y; Xu L; Zhang J
Adv Rheumatol; 2023 May; 63(1):22. PubMed ID: 37194022
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonia: similarity and difference.
Bryson T; Sundaram B; Khanna D; Kazerooni EA
Semin Ultrasound CT MR; 2014 Feb; 35(1):29-38. PubMed ID: 24480141
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.
Jain S; Shahane A; Derk CT
Inflamm Allergy Drug Targets; 2012 Aug; 11(4):266-77. PubMed ID: 22506881
[TBL] [Abstract][Full Text] [Related]
8. [Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren's syndrome: a case report].
Yu JF; Jin YB; He J; An Y; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):910-914. PubMed ID: 29045979
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of fibrosing diffuse parenchymal lung disease.
Morgenthau AS; Padilla ML
Mt Sinai J Med; 2009 Feb; 76(1):2-23. PubMed ID: 19170214
[TBL] [Abstract][Full Text] [Related]
10. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
Front Immunol; 2020; 11():1990. PubMed ID: 33013852
[TBL] [Abstract][Full Text] [Related]
11. Progressive systemic sclerosis and the lung.
Veeraraghavan S; Sharma OP
Curr Opin Pulm Med; 1998 Sep; 4(5):305-9. PubMed ID: 10813207
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway.
Yang G; Lyu L; Wang X; Bao L; Lyu B; Lin Z
Pulm Pharmacol Ther; 2019 Jun; 56():69-74. PubMed ID: 30930172
[TBL] [Abstract][Full Text] [Related]
13. [Collagen diseases with pulmonary involvement].
Kuwana M
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Jun; 27(3):118-26. PubMed ID: 15291248
[TBL] [Abstract][Full Text] [Related]
14. The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease.
Talotta R
Immunotherapy; 2021 Feb; 13(3):241-256. PubMed ID: 33410346
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.
Jung SM; Park KS; Kim KJ
Ann Rheum Dis; 2022 Jan; 81(1):108-116. PubMed ID: 34380701
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms.
Paulin F; Doyle TJ; Fletcher EA; Ascherman DP; Rosas IO
Rev Invest Clin; 2015; 67(5):280-6. PubMed ID: 26696331
[TBL] [Abstract][Full Text] [Related]
17. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis.
de Souza RB; Borges CT; Capelozzi VL; Parra ER; Jatene FB; Kavakama J; Kairalla RA; Bonfá E
Respiration; 2009; 77(4):389-97. PubMed ID: 18799868
[TBL] [Abstract][Full Text] [Related]
18. Practical Approach to the Evaluation and Management of Rheumatoid Arthritis-Interstitial Lung Disease Based on its Proven and Hypothetical Mechanisms.
Paulin F; Babini A; Mamani M; Mercado J; Caro F
Rev Invest Clin; 2017; 69(5):235-242. PubMed ID: 29077694
[TBL] [Abstract][Full Text] [Related]
19. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.
Fischer A; Distler J
Clin Rheumatol; 2019 Oct; 38(10):2673-2681. PubMed ID: 31423560
[TBL] [Abstract][Full Text] [Related]
20. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.
Maurer B; Reich N; Juengel A; Kriegsmann J; Gay RE; Schett G; Michel BA; Gay S; Distler JH; Distler O
Ann Rheum Dis; 2012 Aug; 71(8):1382-7. PubMed ID: 22523431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
